Skip to main content

Hobbs and Duncan win $3.9M NIAID grant to study a meningitis vaccine’s effect on gonorrhea

August 26, 2021

The NIH’s National Institute of Allergy and Infectious Diseases has awarded UNC’s Marcia Hobbs and Alex Duncan a five-year, $3.9 million grant to study how a vaccine recently developed to prevent life-threatening infections caused by group B Neisseria meningitidis, the MenB vaccine, may also protect people from infection with Neisseria gonorrhoeae, a sexually transmitted bacterial … Continued

Current status of COVID-19 vaccine development

February 19, 2021

Presented by Larry Corey, MD Past President and Director, Professor of Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center Professor, Medicine and Laboratory Medicine, University of Washington Corey is an internationally renowned expert in virology, immunology and vaccine development. His research focuses on herpes viruses, HIV, the novel coronavirus, and other viral infections, … Continued

Researchers receive up to $10.7 million to study chlamydia vaccine

May 30, 2019

  Chlamydia is the most prevalent bacterial sexually transmitted infection (STI) in the world. There is no vaccine to prevent infection. However, researchers from the University of North Carolina at Chapel Hill, in partnership with colleagues at other sites in the U.S., Europe and Australia, will receive up to $10.7 million over five years from … Continued